These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30368004)

  • 1. The Severe Asthma Network in Italy: Findings and Perspectives.
    Heffler E; Blasi F; Latorre M; Menzella F; Paggiaro P; Pelaia G; Senna G; Canonica GW;
    J Allergy Clin Immunol Pract; 2019; 7(5):1462-1468. PubMed ID: 30368004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Canonica GW; Malvezzi L; Blasi F; Paggiaro P; Mantero M; Senna G; Heffler E;
    Respir Med; 2020 May; 166():105947. PubMed ID: 32250875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA).
    Bilò MB; Antonicelli L; Carone M; De Michele F; Menzella F; Musarra A; Tognella S; Vaghi A; Micheletto C
    Eur Ann Allergy Clin Immunol; 2021 May; 53(3):103-114. PubMed ID: 33728838
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry.
    Malipiero G; Paoletti G; Blasi F; Paggiaro P; Senna G; Latorre M; Caminati M; Carpagnano GE; Crimi N; Spanevello A; Aliberti S; Canonica GW; Heffler E
    Expert Rev Respir Med; 2021 Mar; 15(3):419-424. PubMed ID: 33100041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RItA: The Italian severe/uncontrolled asthma registry.
    Maio S; Baldacci S; Bresciani M; Simoni M; Latorre M; Murgia N; Spinozzi F; Braschi M; Antonicelli L; Brunetto B; Iacovacci P; Roazzi P; Pini C; Pata M; La Grasta L; Paggiaro P; Viegi G;
    Allergy; 2018 Mar; 73(3):683-695. PubMed ID: 29072882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.
    Bisaccioni C; Aun MV; Cajuela E; Kalil J; Agondi RC; Giavina-Bianchi P
    Clinics (Sao Paulo); 2009; 64(8):769-73. PubMed ID: 19690661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world assessment of asthma with chronic rhinosinusitis.
    Ricciardolo FLM; Levra S; Sprio AE; Bertolini F; Carriero V; Gallo F; Ciprandi G
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):65-71. PubMed ID: 32171930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopy in chronic rhinosinusitis: impact on quality of life outcomes.
    Ho J; Alvarado R; Rimmer J; Sewell WA; Harvey RJ
    Int Forum Allergy Rhinol; 2019 May; 9(5):501-507. PubMed ID: 30604578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe asthma in Kuwait population: Phenotype-based approach.
    Al-Ahmad M; Nurkic J; Othman Y; Jusufovic E; Maher A
    Respir Med; 2021 Oct; 187():106586. PubMed ID: 34474336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
    Wechsler ME; Scelo G; Larenas-Linnemann DES; Torres-Duque CA; Maspero J; Tran TN; Murray RB; Martin N; Menzies-Gow AN; Hew M; Peters MJ; Gibson PG; Christoff GC; Popov TA; Côté A; Bergeron C; Dorscheid D; FitzGerald JM; Chapman KR; Boulet LP; Bhutani M; Sadatsafavi M; Jiménez-Maldonado L; Duran-Silva M; Rodriguez B; Celis-Preciado CA; Cano-Rosales DJ; Solarte I; Fernandez-Sanchez MJ; Parada-Tovar P; von Bülow A; Bjerrum AS; Ulrik CS; Assing KD; Rasmussen LM; Hansen S; Altraja A; Bourdin A; Taille C; Charriot J; Roche N; Papaioannou AI; Kostikas K; Papadopoulos NG; Salvi S; Long D; Mitchell PD; Costello R; Sirena C; Cardini C; Heffler E; Puggioni F; Canonica GW; Guida G; Iwanaga T; Al-Ahmad M; García U; Kuna P; Fonseca JA; Al-Lehebi R; Koh MS; Rhee CK; Cosio BG; Perez de Llano L; Perng DS; Huang EW; Wang HC; Tsai MJ; Mahboub B; Salameh LIJ; Jackson DJ; Busby J; Heaney LG; Pfeffer PE; Goddard AG; Wang E; Hoyte FCL; Chapman NM; Katial R; Carter V; Bulathsinhala L; Eleangovan N; Ariti C; Lyu J; Porsbjerg C; Price DB
    Am J Respir Crit Care Med; 2024 Feb; 209(3):262-272. PubMed ID: 38016003
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aeroallergen sensitization influences quality of life and comorbidities in patients with nasal polyposis.
    Dávila I; Rondón C; Navarro A; Antón E; Colás C; Dordal MT; Ibáñez MD; Fernández-Parra B; Lluch-Bernal M; Matheu V; Montoro J; Sánchez MC; Valero A
    Am J Rhinol Allergy; 2012; 26(5):e126-31. PubMed ID: 23168143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
    Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
    J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly.
    Song WJ; Sintobin I; Sohn KH; Kang MG; Park HK; Jo EJ; Lee SE; Yang MS; Kim SH; Park HK; Kwon YE; Kim TB; Kim SH; Park HW; Chang YS; Lee BJ; Jee YK; Choi BW; Bachert C; Cho SH
    Clin Exp Allergy; 2016 Mar; 46(3):411-21. PubMed ID: 26436720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
    Schleich F; Brusselle G; Louis R; Vandenplas O; Michils A; Pilette C; Peche R; Manise M; Joos G
    Respir Med; 2014 Dec; 108(12):1723-32. PubMed ID: 25456708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis Fungoides and Its Relationship to Atopy, Serum Total IgE, and Eosinophil Counts.
    Vonderheid EC; Hamilton RG; Kadin ME
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):279-288.e7. PubMed ID: 33342729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Bagnasco D; Brussino L; Bonavia M; Calzolari E; Caminati M; Caruso C; D'Amato M; De Ferrari L; Di Marco F; Imeri G; Di Bona D; Gilardenghi A; Guida G; Lombardi C; Milanese M; Nicolini A; Riccio AM; Rolla G; Santus P; Senna G; Passalacqua G
    Respir Med; 2020 Sep; 171():106080. PubMed ID: 32917354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response?
    Portacci A; Dragonieri S; Carpagnano GE
    Expert Rev Respir Med; 2024 May; 18(5):249-253. PubMed ID: 38845590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.